MedTech News
.................... by Andrew Celentano
StimCardio Closes Oversubscribed $30 Million Series A for Wearable Atrial Fibrillation Therapy
StimCardio, a Los Angeles, CA-based clinical-stage medical device company developing non-invasive wearable therapeutics for atrial fibrillation (AF), has announced the closing of its oversubscribed $30 million Series A financing.
Blood test offers new way to track lung cancer
Northwestern Medicine scientists and collaborators have demonstrated a novel liquid biopsy technique that can measure cancer burden and reveal molecular characteristics of small cell lung cancer (SCLC), according to a new study published in the Journal of Clinical Investigation.
Immune system protein is a cancer killer on its own, new study shows
For decades, scientists have known that a protein made by T cells and natural killer (NK) cells in the immune system, called perforin, can kill tumor cells by punching a hole in the cell wall and injecting proteases called granzymes, which kill the cell. Now, new work led by researchers at the University of Michigan Health Rogel Cancer Center found that tumor cells could be killed even when major granzymes were missing.
A soft robot could help doctors diagnose and treat disorders of the small intestine
MIT engineers designed a robotic enteroscope that can inch through the hard-to-reach small intestine, making biopsies and drug delivery easier.
Capturing the complete process of embryonic development
By tracking over 1 million cells, researchers created a detailed map of embryonic development in mice. It could provide development and disease insights.
Empatica launches WellPD, an FDA-cleared Parkinson’s monitoring device for home use
BOSTON, Oct. 28, 2026 /PRNewswire/ — Empatica, a leader in digital biomarker development and clinical-grade wearable technology, today announced WellPD, an FDA-cleared and CE-marked wearable device and companion app for people with Parkinson’s to monitor their symptoms at home.
FDA clears Deep Reasoning AI’s NeuroDR for neurovascular CT scans
The clearance was secured 105 days after submission, with Deep Reasoning AI now planning to supply the platform in the US.
Pharaoh Neuro’s CSF filtration system wins FDA breakthrough designation
Pharaoh Neuro’s minimally invasive system for filtering cerebrospinal fluid has received a breakthrough designation from the FDA, with its design to clean out unwanted blood following certain internal brain bleeds